Skip to content Skip to footer
Subscribe Now
Insights+ Key Biosimilars Events of May 2021
INSIGHTS+
Insights+ Key Biosimilars Events of May 2021
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients During the month of May, Samsung initiated patient enrollment in the P-III…
June 3, 20210Comments
Viewpoints_Ken Keller
VIEWPOINTS
PharmaShots Interview: Daiichi Sankyo’s Ken Keller Shares Insights on NICE Recommendation for Enhertu in HER2 Positive Breast Cancer
In an interview with PharmaShots, Ken Keller, President and Chief Executive Officer at Daiichi Sankyo and Global Head of the Daiichi Sankyo Oncology Business shared his views on the NICE CDF recommendation for Enhertu in unresectable or metastatic HER2 positive breast cancer and the company's growth and pipeline. Shots: The recommendation from NICE is based on the…
June 2, 20210Comments
Viewpoints_Neil Solomons
VIEWPOINTS
PharmaShots Interview: Aurinia’s Neil Solomons Shares Insights on the Lupkynis
In an interview with PharmaShots, Neil Solomons, Co-founder and Chief Medical Officer of Aurinia shared his views on the data of Lupkynis (voclosporin) presented at the National Kidney Foundation 2021 Spring Clinical Meetings. Shots: New data analysis from the AURORA and AURA clinical studies shows that Aurinia's therapy demonstrated efficacy across all LN biopsy classes. These data show that treatment…
June 1, 20210Comments
Viewpoints_Neil Moat
VIEWPOINTS
PharmaShots Interview: Abbott’s Neil Moat Shares Insights on the Next Generation TriClip Transcatheter Tricuspid Valve Repair System
In an interview with PharmaShots, Neil Moat, M.D., Chief Medical Officer of Abbott's Structural Heart Business shares his views on the CE mark approval of first-of-its-kind TriClip device. Shots: The new iteration of the device, called TriClip G4, offers new clip sizes and an enhanced leaflet grasping feature for physicians to further customize treatment to the complex tricuspid valve…
May 31, 20210Comments
Viewpoints_Dr. Fahar Merchant
VIEWPOINTS
PharmaShots Interview: Medicenna’s Dr. Fahar Merchant Shares Insights on the Bispecific Superkines
In an interview with PharmaShots, Dr. Fahar Merchant, CEO of Medicenna shares his views on the data of a new type of interleukin called bispecific Superkines, presented at AACR 2021   Shots: Bispecific Superkines can attack cold tumors, weakening the protection given to it by the tumor microenvironment and revealing it to the immune system Medicenna focuses on…
May 26, 20210Comments
Viewpoints_Anthony Costello
VIEWPOINTS
PharmaShots Interview: Medidata’s Anthony Costello Shares Insights on the Transformative Sensor Cloud Platform for Connected Devices and Wearable Sensors in Clinical Trials
In an interview with PharmaShots, Anthony Costello, President, Patient Cloud at Medidata share his views on the launch of Sensor Cloud which is a transformative platform for managing a sensor and digital health technology data during the clinical trials. Shots: The company launches Sensor Cloud for managing sensor and digital health technology data during the clinical trial.…
May 25, 20210Comments
Viewpoints_Dr. Allitia DiBernardo
VIEWPOINTS
PharmaShots Interview: Janssen’s Dr. Allitia DiBernardo Shares Insights on the Availability of Ponvory in the US
In an interview with PharmaShots, Dr. Allitia DiBernardo, Global Head of Medical Affairs for Neurology at the Janssen share her views on the availability of Ponvory in the US for MS patients. Shots: Ponvory offers patients superior efficacy in reducing annualized relapses and brain lesions over established oral therapy teriflunomide (Aubagio), with a safe and generally well-tolerated profile…
May 24, 20210Comments
Medical Device Companies Top 20 2020
TOP 20
Top 20 Medical Device Companies Based on 2020 Revenue
The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020- the companies have shown growth resulting from a rise in the number of healthcare facilities- healthcare expenditure- and technological advancements. Medtronic remains at the top…
May 20, 20210Comments